SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-06-23 10:00
Tx date 2022-06-20
$ONC
Oncolytics Biotech Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$51,299
+45,000 vol
$1.14 each
45,000
Filed 2022-06-23 09:57
Tx date 2022-06-16
$ONC
Oncolytics Biotech Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-08 19:29
Tx date 2022-02-08
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
99 - Correction of information

-475,000 vol
60,649
Filed 2022-02-08 19:26
Tx date 2022-02-08
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
99 - Correction of information

-73,150 vol
36,259
Filed 2022-02-08 19:23
Tx date 2022-01-03
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$60,047
+16,773 vol
$3.58 each
109,409
Filed 2022-02-08 19:15
Tx date 2021-01-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$62,004
+7,534 vol
$8.23 each
92,636
Filed 2022-02-08 19:13
Tx date 2021-01-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately
$62,004
+7,534 vol
$8.23 each
Filed 2021-01-05 19:38
Tx date 2021-01-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately
$63,741
+7,745 vol
$8.23 each
Filed 2021-12-16 21:36
Tx date 2021-12-09
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights

+260,000 vol
1,285,001
Filed 2021-07-23 20:51
Tx date 2021-07-15
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,190
+9,393 vol
$3.64 each
535,649
Filed 2021-07-20 17:49
Tx date 2021-07-15
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,190
+9,393 vol
$3.64 each
Filed 2021-07-20 17:49
Tx date 2021-07-15
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$34,190
+9,393 vol
$3.64 each
535,649
Filed 2021-02-08 11:15
Tx date 2021-02-08
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants

+50,000 vol
274,728
Filed 2021-02-08 11:14
Tx date 2021-02-08
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-50,000 vol
10,000
Filed 2021-01-12 12:21
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-134,270.9865
-8,505 vol
$15.79 each
0
Filed 2021-01-12 12:19
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$78,246
+8,505 vol
$9.20 each
8,505
Filed 2021-01-12 12:12
Tx date 2021-01-08
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-78,246
-8,505 vol
$9.20 each
173,492
Filed 2021-01-05 19:38
Tx date 2021-01-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately
$63,741
+7,745 vol
$8.23 each
92,847
Filed 2021-01-04 13:32
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-398,751.45
-26,970 vol
$14.79 each
0
Filed 2021-01-04 13:30
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$224,929
+26,970 vol
$8.34 each
26,970
Filed 2021-01-04 13:29
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-62,836.25
-4,250 vol
$14.79 each
0
Filed 2021-01-04 13:28
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$31,875
+4,250 vol
$7.50 each
4,250
Filed 2021-01-04 13:26
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-224,929.80
-26,970 vol
$8.34 each
181,997
Filed 2021-01-04 13:24
Tx date 2020-12-31
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-31,875
-4,250 vol
$7.50 each
208,967
Filed 2020-12-28 16:34
Tx date 2020-12-23
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+180,000 vol
287,893
Filed 2020-12-18 20:00
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-827,940.5888
-65,104 vol
$12.72 each
0
Filed 2020-12-18 19:59
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$275,389
+65,104 vol
$4.23 each
65,104
Filed 2020-12-18 19:58
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-160,186.382
-14,162 vol
$11.31 each
0
Filed 2020-12-18 19:57
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$5,381
+14,162 vol
$0.38 each
14,162
Filed 2020-12-18 19:56
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-244,764.98
-21,046 vol
$11.63 each
0
Filed 2020-12-18 19:55
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$7,997
+21,046 vol
$0.38 each
21,046
Filed 2020-12-18 19:53
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-501,159.96
-43,092 vol
$11.63 each
0
Filed 2020-12-18 19:52
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$33,180
+43,092 vol
$0.77 each
43,092
Filed 2020-12-18 19:51
Tx date 2020-12-18
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-275,389.92
-65,104 vol
$4.23 each
213,217
Filed 2020-12-18 19:50
Tx date 2020-12-16
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-5,381.56
-14,162 vol
$0.38 each
278,321
Filed 2020-12-18 19:49
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-7,997.48
-21,046 vol
$0.38 each
292,483
Filed 2020-12-18 19:47
Tx date 2020-12-15
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-33,180.84
-43,092 vol
$0.77 each
313,529
Filed 2020-12-18 19:06
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,255,613.0784
-106,908 vol
$11.74 each
0
Filed 2020-12-18 19:05
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options
$82,319
+106,908 vol
$0.77 each
106,908
Filed 2020-12-18 19:03
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:21
Tx date 2020-12-14
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options
$-82,319.16
-106,908 vol
$0.77 each
356,621
Filed 2020-12-18 17:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership

+463,529 vol
463,529
Filed 2020-12-18 17:42
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:40
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
107,893
Filed 2020-12-18 17:34
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:33
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
Filed 2020-12-18 16:48
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
463,529
Filed 2020-12-18 16:48
Tx date 2011-08-25
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 16:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
Filed 2020-12-18 16:44
Tx date 2020-09-29
$TRIL
Trillium Therapeutics Inc.
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership

-463,529 vol
107,893
Filed 2020-11-13 09:15
Tx date 2018-11-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

+50,000 vol
50,000
Filed 2018-11-15 15:38
Tx date 2018-11-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

+50,000 vol
Filed 2020-09-24 13:10
Tx date 2020-09-22
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+10,000 vol
60,000
Filed 2020-09-24 13:08
Tx date 2020-09-22
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$3,000
+10,000 vol
$0.30 each
224,728
Filed 2020-06-02 17:58
Tx date 2020-06-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+13,306 vol
526,256
Filed 2020-06-02 17:57
Tx date 2020-06-01
$DMAC
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights

+8,102 vol
85,102
Filed 2019-11-12 10:38
Tx date 2019-11-07
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$49,400
+130,000 vol
$0.38 each
571,422
Filed 2019-09-18 10:19
Tx date 2019-09-13
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights

+740,056 vol
1,025,001
Filed 2019-06-27 11:54
Tx date 2019-06-24
$DMA
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+12,950 vol
512,950
Filed 2019-05-27 12:54
Tx date 2019-05-10
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$115,500
+150,000 vol
$0.77 each
441,422
Filed 2019-03-11
Tx date 2019-02-28
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-150,000 vol
0
Filed 2018-12-11
Tx date 2018-12-11
$DMA
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus

+2,250 vol
2,250
Filed 2018-12-11
Tx date 2015-10-23
$DMA
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-15
Tx date 2018-11-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
54 - Exercise of warrants
$-12,500
-50,000 vol
$0.25 each
0
Filed 2018-11-15
Tx date 2018-11-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

+50,000 vol
50,000
Filed 2018-11-15
Tx date 2018-11-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$12,500
+50,000 vol
$0.25 each
214,728
Filed 2018-11-09
Tx date 2018-11-08
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$528,750
+125,000 vol
$4.23 each
291,422
Filed 2018-07-17
Tx date 2012-04-19
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-17
Tx date 2018-07-13
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
16 - Acquisition or disposition under a prospectus exemption
$12,500
+50,000 vol
$0.25 each
50,000
Filed 2018-07-12
Tx date 2018-04-17
$DMA
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$33,600
+60,000 vol
$0.56 each
500,000
Filed 2018-07-04
Tx date 2018-06-30
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-40,000 vol
0
Filed 2017-11-13
Tx date 2017-11-09
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$298,045
+24,390 vol
$12.22 each
166,422
Filed 2017-09-14
Tx date 2017-08-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights

+59,945 vol
284,945
Filed 2017-06-23
Tx date 2017-06-19
$DMA
DiaMedica Therapeutics Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
440,000
Filed 2017-04-18
Tx date 2017-04-18
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,951
+49,728 vol
$0.18 each
164,728
Filed 2017-04-18
Tx date 2017-04-18
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-8,951.04
-49,728 vol
$0.18 each
150,000
Filed 2017-04-17
Tx date 2017-04-13
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$29,970
+166,500 vol
$0.18 each
281,500
Filed 2017-04-17
Tx date 2017-04-17
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-48.96
-272 vol
$0.18 each
199,728
Filed 2017-04-17
Tx date 2017-04-17
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$48.96
+272 vol
$0.18 each
115,272
Filed 2017-04-17
Tx date 2017-04-17
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-68.00
-272 vol
$0.25 each
115,000
Filed 2017-04-17
Tx date 2017-04-13
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-41,625
-166,500 vol
$0.25 each
115,000
Filed 2017-04-17
Tx date 2017-04-13
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-29,970
-166,500 vol
$0.18 each
200,000
Filed 2017-04-12
Tx date 2017-04-11
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,375
-33,500 vol
$0.25 each
115,000
Filed 2017-04-12
Tx date 2017-04-11
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$6,030
+33,500 vol
$0.18 each
148,500
Filed 2017-04-12
Tx date 2017-04-11
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-6,030
-33,500 vol
$0.18 each
366,500
Filed 2016-12-02
Tx date 2016-11-28
$DMA
DiaMedica Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$14,630
+77,000 vol
$0.19 each
77,000
Filed 2016-12-02
Tx date 2016-11-28
$DMA
DiaMedica Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
340,000
Filed 2016-12-02
Tx date 2015-10-23
$DMA
DiaMedica Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-10
Tx date 2016-11-09
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$131,247
+14,266 vol
$9.20 each
142,032
Filed 2016-11-10
Tx date 2016-08-25
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-12,510
-417 vol
$30.00 each
127,766
Filed 2016-07-06
Tx date 2016-06-30
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$10,000
+40,000 vol
$0.25 each
115,000
Filed 2016-07-06
Tx date 2012-04-19
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
75,000
Filed 2016-07-06
Tx date 2012-04-19
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-06
Tx date 2016-06-30
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+40,000 vol
40,000
Filed 2016-05-30
Tx date 2016-05-27
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+30,171 vol
128,183
Filed 2016-03-14
Tx date 2016-03-14
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights

+100,000 vol
225,000
Filed 2015-12-15
Tx date 2015-10-23
$DMA
DiaMedica Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-15
Tx date 2015-12-01
$DMA
DiaMedica Inc.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$36,000
+240,000 vol
$0.15 each
240,000
Filed 2015-11-20
Tx date 2015-11-19
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+30,171 vol
98,012
Filed 2015-06-29
Tx date 2012-04-19
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-29
Tx date 2015-06-25
$SVA
Sernova Corp.
Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights

+125,000 vol
125,000
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+4,250 vol
1,899,875
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-127,514 vol
1,895,625
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+417 vol
2,023,139
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+36,204 vol
849,960
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-809,089 vol
40,871
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

+26,970 vol
67,841
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-12,500 vol
2,022,722
Filed 2015-05-22
Tx date 2014-11-14
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,086,119 vol
813,756